Data protection Impressum

Personalized Medicine

Cellestia Biotech is pioneering innovative therapeutics based on novel modes of action to treat autoimmune diseases and multi-drug resistant cancers.

Cellestia Biotech receives CHF 2 million for its pioneering GvHD prevention therapy

23 January 2024

STALICLA has developed the first neurodevelopmental disorder-specific precision medicine platform with an initial application in autism spectrum disorder (ASD).

STALICLA secures USD 17.4 million to propel neuro precision medicine

22 January 2024

For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation with economic growth.

The remarkable chemical-pharmaceutical industry in the canton of Valais

This funding and partnership with the ADDF place GliaPharm at the forefront of developing effective treatments for Alzheimer’s, offering new hope in the fight against this challenging neurodegenerative disease.

GliaPharm receives USD 4.2 million to propel Alzheimer’s treatment development

20 December 2023

The DayOne Health 4.0 accelerator, known for fostering early to mid-stage digital health startups, provides comprehensive support including personalized coaching, expert inputs, and access to key healthcare stakeholders.

machineMD joins top five in DayOne Health 4.0 accelerator’s second phase

19 December 2023

Top Stories Western Switzerland

Business environment

Top Stories from Western Switzerland (October-December 2023)

19 December 2023

This significant funding propels the Diatheris’ efforts to revolutionize type 1 diabetes management through innovative treatment methodologies (from left to right: Pr. Roberto Coppari and Dr Giorgio Rimadori).

Diatheris to spearhead a new era in Type 1 diabetes management

11 December 2023

This institute will contribute significantly to the Swiss healthcare system by developing innovative solutions that focus on patient empowerment and engagement in health management.

Bern University of Applied Sciences launches the Institute for Patient-Centered Digital Health

4 December 2023

EPFL’s innovation is designed to significantly enhance clinical decision-making by providing access to specialized medical knowledge.

Meditron, EPFL’s new Large Language Model for medical knowledge

29 November 2023

Medtech start-ups from Western Switzerland are making significant strides in healthcare, bringing forth innovative solutions for critical medical challenges such as heart valve diseases, grave skin defects, and erectile dysfunction.

Western Switzerland medtech start-ups embark on human trials

29 November 2023

1 … 4 5 6 7 8 9 10 11 12 … 17